Patent: 7,498,043
✉ Email this page to a colleague
Summary for Patent: 7,498,043
Title: | Silicon substituted oxyapatite |
Abstract: | The invention is a silicon substituted oxyapatite compound (Si--OAp) for use as a synthetic bone biomaterial either used alone or in biomaterial compositions. The silicon substituted oxyapatite compound has the formula Ca.sub.5(PO.sub.4).sub.3-x(SiO.sub.4).sub.xO.sub.(1-x)/2, where 0<x<1.0. |
Inventor(s): | Sayer; Michael (Kingston, CA), Reid; Joel (Kingston, CA), Smith; Timothy J. N. (Kingston, CA), Hendry; Jason (Kingston, CA) |
Assignee: | Warsaw orthopedic, inc. (Warsaw, IN) |
Application Number: | 11/088,094 |
Patent Claims: | see list of patent claims |
Details for Patent 7,498,043
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Nps Pharmaceuticals, Inc. | NATPARA | parathyroid hormone | For Injection | 125511 | 01/23/2015 | ⤷ Try a Trial | 2039-03-29 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |